Misonix (Misonix) Dividends per Share : $0.00 (TTM As of Jun. 2021)

View and export this data going back to 2019. Start your Free Trial

What is Misonix Dividends per Share?

Misonix's dividends per share for the three months ended in Jun. 2021 was $0.00. Its dividends per share for the trailing twelve months (TTM) ended in Jun. 2021 was $0.00. Its Dividend Payout Ratio for the three months ended in Jun. 2021 was 0.00. As of today, Misonix's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

Misonix Dividends per Share Historical Data

The historical data trend for Misonix's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Misonix Dividends per Share Chart

Misonix Annual Data

Trend

Jun12

Jun13

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Dividends per Share

Get a 7-Day Free Trial

Misonix Quarterly Data
	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21
Dividends per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Misonix's Dividends per Share

For the Medical Devices subindustry, Misonix's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Misonix's Dividend Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Misonix's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Misonix's Dividend Yield % falls into.

Misonix Dividends per Share Calculation

Dividends paid to per common share.

Misonix (NAS:MSON) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Misonix's Dividend Payout Ratio for the quarter that ended in Jun. 2021 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Jun. 2021 )	/	EPS without NRI (Q: Jun. 2021 )
	=	0	/	-0.26
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Misonix Dividends per Share Related Terms

Thank you for viewing the detailed overview of Misonix's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Misonix (Misonix) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Misonix Inc (NAS:MSON) » Definitions » Dividends per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

1938 New Highway, Farmingdale, NY, USA, 11735

Website

https://www.misonix.com

Misonix Inc is a medical devices company. It designs, manufactures, markets, and sells invasive surgical ultrasonic medical devices. The company's products enhance clinical outcomes and provide value to the overall healthcare system. It has developed products such as BoneScalpel, NeXus, Sequel, SonaStar, SonicOne, Theragenesis, TheraSkin, and Therion. These products are used for precise bone sculpting, removal of soft and hard tumors, tissue debridement, primarily in the areas of neurosurgery, orthopedic surgery, plastic surgery, wound care, and maxillo-facial surgery. The company generates revenue from various regions that include the United States, the United Kingdom, the European Economic Area, Asia and the Asia Pacific, and South America.

Executives

Paul A Laviolette	director	ONE BOSTON PLACE, 201 WASHINGTON STREET, SUITE 3900, BOSTON MA 02108
Sharon W Klugewicz	officer: Chief Operating Officer	3661 HORSEBLOCK ROAD, MEDFORD NY 11763
Thomas M Patton	director	C/O OSTEOTCH INC., 51 JAMES WAY, EATONTOWN NJ 07724
Joseph P Dwyer	officer: Chief Financial Officer	3 CORDWOOD COURT, E. NORTHPORT NY 11731
Gwendolyn A Watanabe	director	C/O SARATOGA VENTURES, 210 ALMENDRA AVENUE, LOS GATOS CA 95030
Linwood A. Staub	officer: Sr. VP Wound	8023 VANTAGE DRIVE SAN ANTONIO TX 78230
Stavros G. Vizirgianakis	director, officer: CEO	1/16-18 TENNYSON ST., WILLIAMSTOWN NORTH, VICTORIA CA 3016
Robert S Ludecker	officer: SVP Sales - Surgical	4 WILDBRIAR COURT MOUNT SINAI NY 11766
Allan Richard Staley	officer: President	C/O SOLSYS MEDICAL, LLC 600 THIMBLE SHOALS BLVD., SUITE 200 NEWPORT NEWS VA 23606
Michael Koby	director	C/O 1315 CAPITAL 2929 WALNUT STREET, SUITE 1240 PHILADELPHIA PA 19104
1315 Capital Management, Llc	10 percent owner	2929 WALNUT STREET SUITE 1240 PHILADELPHIA PA 19104
Sv Life Sciences Fund Vi (gp), L.p.	10 percent owner	ONE BOSTON PLACE, 201 WASHINGTON STREET, SUITE 3900, BOSTON MA 02108
Svlsf Vi, Llc	10 percent owner	ONE BOSTON PLACE, 201 WASHINGTON STREET, SUITE 3900, BOSTON MA 02108
Sv Life Sciences Fund Vi Strategic Partners, L.p.	10 percent owner	C/O SV LIFE SCIENCES ADVISERS, LLC, ONE BOSTON PLACE, SUITE 3900, BOSTON MA 02108
1315 Capital, L.p.	10 percent owner	3020 MARKET STREET, SUITE 104 PHILADELPHIA PA 19104